Costs and trends in pancreatic cancer treatment

摘要: BACKGROUND: Pancreatic cancer poses a substantial morbidity and mortality burden in the United States, predominantly affects older adults. The objective of this study was to estimate direct medical costs pancreatic treatment population-based cohort Medicare beneficiaries, contribution different modalities health care services total cost trends over time. METHODS: In linked Surveillance, Epidemiology, End Results (SEER)-Medicare database, patients were identified who aged 66 years or diagnosed from 2000 2007. Total estimated payments overall within categories care. Costs attributable by subtracting matched cancer-free beneficiaries. RESULTS: A 15,037 identified, whom 97% observed diagnosis until death. Mean $65,500. greater for with resectable locoregional disease ($134,700) than those unresectable distant ($65,300 $49,000, respectively). Hospitalizations cancer-directed procedures collectively accounted largest fraction costs. appeared increase slightly period (P = .05). mean $61,700. CONCLUSIONS: Despite poor prognosis short survival, economic elderly is substantial. Demographic trends, use targeted therapies, possible implementation screening strategies are likely impact patterns future. Cancer 2012. © 2012 American Society.